These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34432365)

  • 1. Assessing methotrexate intolerance and its prevalence in rheumatoid arthritis: Development and validation of the MISA questionnaire.
    Vijaykumar D; Dhir V; Jain S; Pai V; Kaur J; Naidu GS; Sharma A; Khanna Sharma S; Jain S
    Int J Rheum Dis; 2021 Oct; 24(10):1294-1301. PubMed ID: 34432365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of methotrexate intolerance among patients with rheumatoid arthritis using the Arabic version of the methotrexate intolerance severity score.
    Albaqami J; Alshalhoub R; Almalag H; Dessougi M; Al Harthi A; Bedaiwi MK; Omair MA
    Int J Rheum Dis; 2019 Aug; 22(8):1572-1577. PubMed ID: 31245906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of oral methotrexate intolerance in Japanese adult patients with rheumatoid arthritis.
    Kanda M; Sato M; Nagahata K; Naishiro Y; Murakami R; Honda S; Suzuki C
    Int J Rheum Dis; 2024 Jan; 27(1):e15029. PubMed ID: 38287557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire).
    Fatimah N; Salim B; Nasim A; Hussain K; Gul H; Niazi S
    Clin Rheumatol; 2016 May; 35(5):1341-5. PubMed ID: 27053094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS).
    Amaral JM; Brito MJM; Kakehasi AM
    Adv Rheumatol; 2020 Aug; 60(1):43. PubMed ID: 32843102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis.
    Ćalasan MB; van den Bosch OF; Creemers MC; Custers M; Heurkens AH; van Woerkom JM; Wulffraat NM
    Arthritis Res Ther; 2013; 15(6):R217. PubMed ID: 24345416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary results.
    Höfel L; Eppler B; Storf M; Schnöbel-Müller E; Haas JP; Hügle B
    Pediatr Rheumatol Online J; 2018 Feb; 16(1):11. PubMed ID: 29433504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Ondansetron in Reducing Methotrexate Intolerance in Patients with Inflammatory Arthritis.
    Saif S; Kakalia S; Kitchlew R; Khan HA; Fida S; Siddique M
    J Coll Physicians Surg Pak; 2022 Oct; 32(10):1308-1312. PubMed ID: 36205276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.
    van Dijkhuizen EH; Pouw JN; Scheuern A; Hügle B; Hardt S; Ganser G; Kümmerle-Deschner JB; Horneff G; Holzinger D; Bulatović Ćalasan M; Wulffraat NM
    Clin Exp Rheumatol; 2016; 34(1):148-54. PubMed ID: 26843067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score.
    Bulatović M; Heijstek MW; Verkaaik M; van Dijkhuizen EH; Armbrust W; Hoppenreijs EP; Kamphuis S; Kuis W; Egberts TC; Sinnema G; Rademaker CM; Wulffraat NM
    Arthritis Rheum; 2011 Jul; 63(7):2007-13. PubMed ID: 21437879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world data on MTX tolerance with regimens used in children versus adults.
    Kaya Akca U; Farisogullari B; Yardimci GK; Sag E; Atalay E; Kasap Cuceoglu M; Basaran O; Kilic L; Ozen S; Bilginer Y
    Clin Rheumatol; 2021 Dec; 40(12):5095-5102. PubMed ID: 34218394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MISS questionnaire in French version: a good tool for children and parents to assess methotrexate intolerance.
    Chausset A; Fargeix T; Pereira B; Echaubard S; Duquesne A; Desjonquères M; Freychet C; Belot A; Merlin E
    Clin Rheumatol; 2017 Jun; 36(6):1281-1288. PubMed ID: 28477218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): effect of adding caffeine to the management regimen.
    Malaviya AN
    Clin Rheumatol; 2017 Feb; 36(2):279-285. PubMed ID: 27596742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis.
    Dalkilic E; Sahbazlar M; Gullulu M; Yavuz M; Dilek K; Ersoy A; Ozkaya G; Yurtkuran M
    Mod Rheumatol; 2013 May; 23(3):525-8. PubMed ID: 22752502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of methotrexate on gastrointestinal symptoms in patients with rheumatoid arthritis.
    Asai S; Nagai K; Takahashi N; Watanabe T; Matsumoto T; Asai N; Sobue Y; Ishiguro N; Kojima T
    Int J Rheum Dis; 2019 Feb; 22(2):207-213. PubMed ID: 30168274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
    Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B
    J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cultural Adaptation and Validation of the Methotrexate Intolerance Severity Score in Brazilian Portuguese for Adults With Rheumatoid Arthritis.
    Amaral JM; Brito MJM; Kakehasi AM
    J Clin Rheumatol; 2021 Sep; 27(6S):S168-S172. PubMed ID: 31789997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.